NCT00003027 2023-06-22
Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
Eastern Cooperative Oncology Group
Phase 3 Completed
Clinical Trials
8 trialsNCT00006264 2016-02-03
Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT00006237 2015-03-25
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
SWOG Cancer Research Network
Phase 3 Completed
NCT00070187 2013-10-17
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Children's Oncology Group
Phase 2/3 Completed
NCT00009698 2013-06-28
Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
Children's Oncology Group
Phase 1 Completed
NCT00053807 2012-09-24
Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00002669 2012-07-02
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00003148 2012-07-02
Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed